54M, “favorable” prostate cancer diagnosis — surgery vs. radiation
Background: Diagnosed via MRI-fusion biopsy — Gleason 3+4=7 (Grade Group 2), 50% of one core involved (10-25% pattern 4), plus a smaller Gleason 3+3=6 (Grade Group 1) area, 5% involvement. No cribriform or intraductal pattern. Staging clean — MRI shows intact capsule, CT urogram shows no nodes or bone lesions. PSA 1.9–2.3 ng/mL. Clinical stage T1c/T2a N0M0.
Surgeon’s input: Recommends treatment over active surveillance (says it can cut 10-year metastasis risk in half). Considers surgery and radiation+hormones roughly equivalent for long-term cure, differing mainly in side-effect profile. Mentioned focal therapy as an option for patients prioritizing quality of life if disease is unifocal.
Surgical risks discussed (robotic prostatectomy):
* Overall complication rate ~12%
* <2% DVT/PE, <2% major cardiac/stroke event, <1% rectal injury
* 5–10% urinary leakage at 1 year (pad use); initial leakage common for 3–6 months
* 0.5% risk of needing sphincter surgery
* ED risk depends on age, baseline function, nerve-sparing extent
* 1–2 weeks with catheter, 6-week lifting restriction, 1-day hospital stay
Radiation Therapy Risks:
* Potential longer term risk of secondary cancers caused by radiation
* Longer term risk of bowel and or bladder complications
* Makes salvage surgery very complex if cancer returns to the prostate (<5% chance)
My questions for the group:
1. Nerve-sparing prostatectomy vs. proton therapy with SpaceOAR (rectal spacer) — how do these compare for long-term (20+ year) outcomes, not just 10-year cure rates?
2. Real-world experiences with incontinence, ED, and any penile shortening after each approach?
3. Anyone with a similar Gleason 3+4 profile who chose one over the other and how it’s held up years later?
Interested in more discussions like this? Go to the Prostate Cancer Support Group.
Connect

@jeffmarc Fabulous summary! And to my knowledge, about as accurate as one can get. I too had genetic testing done when first diagnosed 8-years ago. It took almost 6-months to get the results, but I was told by that specialty group, that I too, lacked the two BRCA-1 and -2 mutations of genetically induced prostate cancer, and that my specific case, was strictly a "lifestyle disease" (i.e., I did not "inherit" the disease, nor could I pass it on to male children). My radiation oncologist later concurred with that genetic assessment, and notably, my own father died at age 80 of bladder cancer (never having had prostate issues).
As for the incidence of secondary cancers occurring to non-target tissues from radiation treatments later in life, again, my oncologist fully agreed with what's been said here. He stated that the reported incidence of such "secondary" cancers, was well below 3%, and that the vast majority of that 3% did not occur for 10 or more years. For what its worth, he had also stated at one point, that the radiation level of IMRT (external beam radiation), was roughly twice the strength of an average x-ray.
-
Like -
Helpful -
Hug
5 ReactionsSupposed to get my decipher results next week 2 of 12 cores 3+4, 20% involvement with 10% of 4 and 30% involvement and 30%of 4. If the test comes in low probably will do sbrt 5 treatments 2 1/2 weeks without adt otherwise nerve sparing surgery, have Urology surgeon appointment in 3 weeks.
-
Like -
Helpful -
Hug
3 Reactions@brianjarvis Thanks for the link and time bookmark. I’ve been reading about higher dose presenting better outcomes so it was very interesting to hear his input on the SBRT vs more treatment sessions at lower rad level.
My Pet scan should help provide some clarity on whether I should search out a good Rs-Ralp or look into this type of rad treatment.
It did seem like many of those studies from the video also involved ADT even for the G6 group. Is that fairly standard procedure and something you also had done?
-
Like -
Helpful -
Hug
1 Reaction@toomany @jeffmarc
Dr Patrick Walsh book also had an interesting discussion that men with the defective Brca2 tended to have cancer with more aggressive features. Unfortunately it appears the lab which performed my biopsy is still trying to locate my saliva sample for this
-
Like -
Helpful -
Hug
1 Reaction@toomany
Just to let you know about one point You were making.
“ nor could I pass it on to male children”
Unfortunately, this comment from the doctor is not true. A father or brother having prostate cancer more than increases the chance of the child/brother having it by More than double over a normal Chance of getting it. This is not me saying it. This is something that’s been presented by doctors at multiple prostate cancer forums I’ve been to..
My father died of prostate cancer. I got it at 62 because of him and because my mother gave me BRCA2. My brother got it at 77 because my father died of it and he did not get anything from my mother. You’ll find many generations of families that have prostate cancer passed from father to son. If there’s a genetic issue, then the child can get it younger.
-
Like -
Helpful -
Hug
2 Reactions@ireland1964
They can do it with blood as well. I’ve had it done both ways.
Yes, some men with BRCA2 do have very aggressive cases. Mine keeps coming back, but fortunately the newer drugs we have today keep it under control.
-
Like -
Helpful -
Hug
4 Reactions@ireland1964 Some guys want their G6 treated; I didn’t. (I was on active surveillance with a G6 for 9 years.) Like any other disease, illness, or injury, I don’t get treatment unless it’s medically necessary. Rarely is treatment for a G6 medically necessary.
The issue with moving too quickly to treating a Gleason 6(3+3) is that there’s some debate in the medical community as to whether a G6 should even be called “cancer.” Some in the medical community say that a “3” cell structure can’t metastasize and therefore shouldn’t be considered cancer like a G7+. (That a “true” 6(3+3) is a harmless benign tumor - that it shouldn’t necessarily be treated.) Others in the medical community disagree. So, the debate continues.
This is a presentation by Dr. Scholz referencing a study involving 26,000 cases that concluded that a “true” Gleason 6(3+3), never metastasizes: https://youtu.be/NV8QHzbgamI
-
Like -
Helpful -
Hug
6 Reactions@jeffmarc Greetings Jeff, and as always, my thanks for your continued contributions to these various threads.
Let me start by saying that I am no trained or educated Geneticist, so I can't really speak to the validity of what was said by those who are, including any difference between 'genes' themselves and 'mutations' of those same genes, or whether such mutations can be congenital (i.e., passed-on, etc.)? I'm afraid all of that is well above my own pay-grade.
However, I do wish to clarify that it was not my oncologist, or a "doctor" of any kind, who had conveyed that information to me. Rather, it was a senior researcher of the genealogical group at the Huntsman Cancer Institute, entitled the Utah Population Database (UPDB), which links multi-generational family trees to medical and public health records. My "doctor" (or oncologist), simply concurred with it.
-
Like -
Helpful -
Hug
1 Reaction@toomany Why
I suspect this is a genetic problem that they just don’t know about yet. The genome is just not that well-known in detail.
@brianjarvis I probably should have worded my comment better.
I was pointing out many people in the case studies which also included G6 from that video also had ADT and was wondering if you did too or know if that seems standard with this treatment?